RESUMO
BACKGROUND: Considering the strong correlation made between Alzheimer's disease (AD) and the pathology of glucose metabolism disorder, we sought to analyze the effects of fasting blood glucose (FBG) level, fasting plasma insulin (FINS) level, and insulin resistance index (HOMA-IR) on the risk and severity of AD. OBJECTIVE: Reveal the pathological relationship between AD and insulin resistance. METHODS: We searched 5 databases from inception through April 4, 2022. Meta-regression was conducted to identify if there were significant differences between groups. Shapiro-Wilk test and the Q-Q diagram were applied to evaluate the normality of variables. A multiple logistic regression model was employed to explore the association between FBG, FINS, HOMA-IR, and Mini-Mental State Examination scale score (MMSE). RESULTS: 47 qualified articles including 2,981 patients were enrolled in our study. FBG (pâ<â0.001), FINS (pâ<â0.001), and HOMA-IR (pâ<â0.001) were higher in AD patients than in controls. HOMA-IR was negatively correlated with MMSE (pâ=â0.001) and positively related to the sex ratio (male versus female) (pâ<â0.05). HOMA-IR obeyed lognormal distribution (pâ>â0.05), and the 95% bilateral boundary values were 0.73 and 10.67. FBG (pâ=â0.479) was positively correlated to MMSE, while FINS (pâ=â0.1657) was negatively correlated with MMSE. CONCLUSION: The increase in the levels of FBG, FINS, and HOMA-IR served as precise indicators of the risk of AD. HOMA-IR was found to be correlated to the increasing severity of AD, especially in male AD patients.